14-day Premium Trial Subscription Sign Up For FreeGet Free

$0.35 (2.87%)

Volume: 3M

Closed: Dec 07, 2021

Hollow Logo Score: -2.457

Advaxis Stock Forecast

$0.35 (2.87%)

Volume: 3M

Closed: Dec 07, 2021

Score Hollow Logo -2.457
Which way will ADXS go? Request
Key Stats
P/E Ratio -2.66
Beta 1.32
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 39 and the stock is currently not being overbought or oversold

Advaxis stock price up 2.87% on Tuesday
(Updated on Dec 07, 2021)

Sell candidate since 2021-11-17 Loss -12.28%

The Advaxis stock price gained 2.87% on the last trading day (Tuesday, 7th Dec 2021), rising from $0.34 to $0.35. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 8.54% from a day low at $0.35 to a day high of $0.38. The price has fallen in 6 of the last 10 days and is down by -3.7% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 105 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $1.01 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.63% during the next 3 months and, with a 90% probability hold a price between $0.22 and $0.31 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, December 03, 2021, and so far it has risen 13.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Advaxis has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Advaxis stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.43. On a fall, the stock will find some support from the short-term average at $0.35. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss

Advaxis finds support from accumulated volume at $0.34 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0299 between high and low, or 8.54%. For the last week, the stock has had a daily average volatility of 10.69%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Advaxis stock A Buy?

Advaxis holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.457

Predicted Opening Price for Advaxis of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$0.36 $0.35 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

Alliance Global Partners is very positive about ADXS and gave it a "Buy" rating on Apr 19, 2021. The price target was changed from $5.00 to $2.25.

Volatility and Risk
Daily Average Volatility: 10.69 %
Overall Risk: Very High High Medium Low Very Low
10.69 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.40
Price: $0.35
Support: $0.34

ADXS Insider Trading Show all Trades



Last 100 transactions
Buy: 3 434 209 | Sell: 1 906 825 (Shares)
Date Action Amount Person Type
May 04, 2020 Buy 13 000 Berman Richard J Option
May 04, 2020 Buy 50 000 Berlin Kenneth A Options
May 04, 2020 Buy 13 000 Patton James P Option
May 04, 2020 Buy 13 000 Khleif Samir N Options
May 04, 2020 Buy 50 000 Gutierrez Andres Options
Show all Insider Trades


Last 100 transactions
Buy: 3 434 209 | Sell: 1 906 825 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.39 10.42 %
0.38 7.20 %
0.37 5.21 %
Current price: 0.35
Support 0.35 -1.24 %
0.34 -3.23 %
0.33 -6.45 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.41 15.27 %
0.40 13.35 %
0.40 12.92 %
Current price 0.35
Support 0.34 -2.79%
0.34 -2.82%
0.31 -12.25%

Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. Its lead product Axalimogene filolisbac (ADXS-HPV), an Lm-LLO immunotherapy product candidate, which completed its Phase II study used for the treatment of human papilloma virus (HPV) associated cancers, including cervical, head and neck, and anal cancer. The company is also dev... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE